Showing results (341-350 of 491) with videos related to
Sort By:
Pageof 50
Protein Science : a Publication of the Protein Society|July 9, 1998
Structure of malonic acid-based inhibitors bound to human neutrophil collagenase. A new binding mode explains apparently anomalous dataH Brandstetter, R A Engh, E G Von Roedern, et al.The Journal of Biological Chemistry|November 22, 1996
X-ray structure of active site-inhibited clotting factor Xa. Implications for drug design and substrate recognitionH Brandstetter, A Kühne, W Bode, et al.Journal of Diabetes Science and Technology|September 2, 2011
A 16-week open-label, multicenter pilot study assessing insulin pump therapy in patients with type 2 diabetes suboptimally controlled with multiple daily injectionsJuan P Frias, Bruce W Bode, Timothy S Bailey, et al.Journal of Molecular Biology|February 5, 1999
The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificityP J Pereira, Z M Wang, H Rubin, et al.Journal of Molecular Biology|June 27, 1997
Crystal structure of an oligomer of proteolytic zymogens: detailed conformational analysis of the bovine ternary complex and implications for their activationF X Gomis-Rüth, M Gómez-Ortiz, J Vendrell, et al.The EMBO Journal|September 2, 1998
Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptorC Fernandez-Catalan, W Bode, R Huber, et al.Angewandte Chemie (International Ed. in English)|February 29, 2024
Peptide-Directed Attachment of Hydroxylamines to Specific Lysines of IgG Antibodies for Bioconjugations with AcylboronatesMatthias Tanriver, Marco Müller, Mikail D Levasseur, et al.The Journal of Biological Chemistry|June 20, 1998
Changing residue 338 in human factor IX from arginine to alanine causes an increase in catalytic activityJ Chang, J Jin, P Lollar, et al.The Journal of Biological Chemistry|June 24, 1994
Crystal structures, spectroscopic features, and catalytic properties of cobalt(II), copper(II), nickel(II), and mercury(II) derivatives of the zinc endopeptidase astacin. A correlation of structure and proteolytic activityF X Gomis-Rüth, F Grams, I Yiallouros, et al.Diabetes Care|July 12, 2014
Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: results of the randomized phase III study in recent-onset human type 1 diabetesRonnie Aronson, Peter A Gottlieb, Jens S Christiansen, et al.Pageof 50